CF PharmTech picks up $90 mln Series E
CF PharmTech Inc, a provider of respiratory drug products, has raised $90 million in Series E funding.
CF PharmTech Inc, a provider of respiratory drug products, has raised $90 million in Series E funding.
Copyright PEI Media
Not for publication, email or dissemination
